Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bio-Rad Laboratories, Inc.    BIO

BIO-RAD LABORATORIES, INC.

(BIO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/23/2021 02/24/2021 02/25/2021 02/26/2021 03/01/2021 Date
594.48(c) 594.74(c) 582.45(c) 584.5(c) 597.3 Last
279 565 197 797 264 731 242 319 157 412 Volume
-1.50% +0.04% -2.07% +0.35% +2.19% Change
More quotes
Financials (USD)
Sales 2021 2 615 M - -
Net income 2021 358 M - -
Net Debt 2021 - - -
P/E ratio 2021 49,3x
Yield 2021 -
Sales 2022 2 738 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 17 526 M 17 526 M -
Capi. / Sales 2021 6,70x
Capi. / Sales 2022 6,40x
Nbr of Employees 8 000
Free-Float 70,9%
More Financials
Company
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and... 
More about the company
All news about BIO-RAD LABORATORIES, INC.
02/22BIO RAD LABORATORIES  : Rad to Participate in Citi's 2021 Healthcare Services, M..
BU
02/16BIO RAD LABORATORIES  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
02/12BIO RAD LABORATORIES  : Citigroup Adjusts Price Target on Bio-Rad Laboratories t..
MT
02/11BIO-RAD LABORATORIES, INC.  : Results of Operations and Financial Condition, Fin..
AQ
02/11BIO RAD LABORATORIES  : Q4 Results Rise From Year Ago, Sets Guidance -- Stock Up..
MT
02/11BIO-RAD : 4Q Earnings Snapshot
AQ
02/11BIO RAD LABORATORIES  : Rad Reports Fourth-Quarter and Full-Year 2020 Financial ..
BU
02/11BIO RAD LABORATORIES  : Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q4 EPS..
MT
02/11BIO RAD LABORATORIES  : Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q4 Rev..
MT
02/04BIO-RAD LABORATORIES, INC.  : Costs Associated with Exit or Disposal Activities ..
AQ
01/25BIO RAD LABORATORIES  : Rad to Report Fourth-Quarter and Full-Year 2020 Financia..
BU
01/08BIO RAD LABORATORIES  : Rad to Participate in Fireside Chat at the 39th Annual J..
BU
2020BIO RAD LABORATORIES  : Zacks Investment Research Downgrades Bio-Rad Laboratorie..
MT
2020BIO RAD LABORATORIES  : Sees Fiscal 2023 Sales of $2.75 Billion to $2.85 Billion..
MT
2020BIO RAD LABORATORIES  : Rad Provides Outlook Through 2023
BU
More news
News in other languages on BIO-RAD LABORATORIES, INC.
2020L'ombre d'un doute
2020EN DIRECT DES MARCHES : Peugeot, Orange, Verallia, Solocal, Valneva, easyJet,..
2020AKTIE IM FOKUS : Sartorius können Rekordhoch nicht verteidigen - Verluste
2019STOCK MARKET PARIS : Paris attend des clarifications
2019Bourse - sartorius stedim biotech gagne 1,9%, jpmorgan ayant entamé le suivi ..
More news
Analyst Recommendations on BIO-RAD LABORATORIES, INC.
More recommendations
Chart BIO-RAD LABORATORIES, INC.
Duration : Period :
Bio-Rad Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIO-RAD LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 655,00 $
Last Close Price 584,50 $
Spread / Highest target 30,0%
Spread / Average Target 12,1%
Spread / Lowest Target -34,1%
EPS Revisions
Managers and Directors
NameTitle
Norman D. Schwartz Chairman, President & Chief Executive Officer
Ilan Daskal Chief Financial Officer & Executive Vice President
Andrew J. Last Chief Operating Officer & Executive Vice President
Jeffrey L. Edwards Independent Director
Gregory K. Hinckley Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIO-RAD LABORATORIES, INC.0.27%17 526
ABBOTT LABORATORIES9.40%212 194
MEDTRONIC PLC-0.15%157 614
BECTON, DICKINSON AND COMPANY-3.62%70 069
ALIGN TECHNOLOGY, INC.6.12%44 717
HOYA CORPORATION-15.21%41 829